Lymphatic disorder may cause stillbirth, chronic disease in affected children

In a breakthrough discovery, South Australian researchers have identified a genetic mutation responsible for a lymphatic disorder that may be responsible for causing stillbirth or severe, chronic disease in affected children.

The findings were published in the journal 'Science Translational Medicine'.

An anomaly in the development of lymphatic vessels in unborn children, leading to fluid accumulating in the heart, lungs, and other organs, was uncovered by the scientists from the Centre for Cancer Biology (CCB) based at the University of South Australia (UniSA) and SA Pathology.

CCB Director Professor Natasha Harvey said a genetic study of six families affected by stillbirth or lymphoedema revealed the link between a mutated protein-coding gene called MDFIC and fluid accumulation in vital organs and tissues.

This demonstrated that MFDIC is important for controlling the growth and development of the lymphatic vessels in the foetus for the first time.

"The lymphatic system is a network of vessels (pipes) and nodes (filters and control centres) important for maintaining fluid balance in our tissues and transporting infection-fighting white blood cells throughout our bodies," Prof Harvey said.

"We determined that MDFIC controls cell migration, an important early event during the formation of the lymphatic vessel valves. The genetic variants we have found in our study reveal a crucial, previously unrecognized role for MDFIC in the lymphatic vasculature."

"If the lymphatic valves don't form properly, lymph fluid accumulates in critical organs such as the heart and lungs, causing major respiratory problems that may eventuate in stillbirth or chronic disease."

An SA Pathology research team headed by Professor Hamish Scott initially found the genetic link in an Australian family. Their international colleagues in Belgium, Germany, and the US reported variants in the same gene, MDFIC, in several patients with the same lymphatic disorder.

Prof Harvey said, the disorder, known as the central conducting lymphatic anomaly (CCLA), is one of a group of severe lymphatic disorders and may result in stillbirth, or severe chronic disease in affected children.

Few effective treatments are available but with continued identification of the genetic causes of CCLAs, Prof Harvey says the next step is to develop new therapeutic drugs to combat the disease.

"There are existing drugs that may be used to treat these disorders, but we need to make sure that the signalling pathway that's treated by those drugs is the same pathway that is affected in our patients.

"This project is about the power of collaboration at a local level, national level, and international level, so that's been really important. Science is done in teams and we have great research teams here in Adelaide at the Centre for Cancer Biology. Our Ph.D. students and postdoctoral fellows have been integral to this work. They have really driven it and we're delighted to be working with such a group of talented people."

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

 

What Is a Cytokine Storm? Doctors Explain How Some COVID-19 Patients' Immune Systems Turn Deadly

 The immune system is there to help us fight infection, but sometimes it wreaks more havoc than the disease itself.

The news cycle is heavily saturated with stress-inducing information about COVID-19, but one of the most worrying aspects so far has been the huge disparity in the way the novel coronavirus presents itself: Why do some people have no symptoms (or only mild ones), while others are so sick they require ventilation?

There isn’t a definitive answer, but many experts suspect our own immune system is to blame for the intense illnesses some people are experiencing. The immune system is there to help us fight infection—and usually it does—but sometimes it goes rogue, wreaking more havoc than the disease itself.

It’s called cytokine storm syndrome (known more broadly as a cytokine storm), and although no one knows for sure how many COVID-19 patients are becoming very ill as a result of this escalated immune response, it’s reasonable to assume that the condition's responsible for at least some of the coronavirus-related fatalities we’ve seen. Here’s everything you need to know.
What is a cytokine storm?

Whenever a healthy body is fighting an infection, there’s a natural immune system response that occurs. According to Carl Fichtenbaum, MD, professor in the division of infectious diseases at the University of Cincinnati College of Medicine, part of this response involves releasing cytokines, biological chemicals that stimulate cell pathways and allow for communication between cells. These cytokines, according to the American Cancer Society, essentially signal the immune system to start doing its job.

Again, that’s normal—unless this outpouring of cytokines suddenly becomes accelerated. "Normally, cytokines are meant to be helpful to us in moderation," explains Dr. Fichtenbaum, "but when a certain pathway is engaged [too much] the immune system starts causing damage to the patient."

Dr. Fichtenbaum says that when most people hear the term "storm," they think of a raining downpour, but that’s not the most accurate way to explain a cytokine storm.

Clinically speaking, a cytokine storm means a cell pathway has been turned on, leading to the production of a number of biological mediators (which are kind of like signal transmitters) that cause changes to the body and interfere with normal cell function. Commonly, this means an excessive number of cytokines are released, which create high levels of inflammation in the area of the body being flooded—so much inflammation, even, that it can be fatal.

"Imagine that you put your foot on the accelerator and it gets glued to it," Dr. Fichtenbaum says. "You can't get your foot off the gas to slow down your car." Essentially, these storms can be more deadly than the original virus the body is fighting.

Are these storms occurring in patients with COVID-19?

Yes, and clinicians aren’t surprised: Cytokine storms can be instigated by a number of infections, including influenza, pneumonia, and sepsis. This heightened immune response doesn’t happen in all patients with severe infections, obviously, but experts don’t know what makes some people more susceptible than others.

That’s especially true with COVID-19, since we know so little about how it works. What doctors do know, at this point, is that some patients are simply becoming very sick, very quickly.

"We’re seeing people across the course of this illness respond in a hyper-inflammatory way," says Deepa Gotur, MD, a critical care physician at Houston Methodist Hospital. "It’s a cascade of cytokines affecting the patient’s lungs, heart, kidneys. The extent [to which their bodies are overreacting] is similar to the way cancer patients respond to infection."

Most of the COVID-19 patients experiencing cytokine storms are presenting with fevers and shortness of breath, then having so much difficulty breathing they eventually require ventilation, says Dr. Gotur. This typically occurs about six or seven days after the onset of illness.
How are cytokine storms detected and treated?

There’s no way to test whether or not someone is experiencing a cytokine storm, though bloodwork may give clinicians clues that a hyper-inflammatory response is happening. "Some clinicians and investigators have been suggesting we do certain blood tests upon hospital admission for warning signs that this might be an impending problem, but that’s a theoretical idea that hasn’t been proven at this time," explains Dr. Fichtenbaum.

Otherwise, doctors are looking at how individual patients are presenting, such as if they are continuing to have breathing difficulty despite receiving oxygen. That might mean their bodies are being flooded with cytokines.

As far as treatment, there are several interventions, like ventilator intubation and extracorporeal membrane oxygenation (ECMO). Doctors are also paying close attention to how patients are responding to some of the treatments being used, like antibody plasma infusions, protein binding medications, and stem cell therapies.

Dr. Fichtenbaum says some clinicians are also using a medication that blocks interleukin-6 (IL-6), one of the key biological mediators responsible for cytokine storms. Anecdotally, these doctors are reporting improvement when treating COVID-19 patients with anti-interleukin-6 medications (or IL-6 inhibitors), which is encouraging, but it’s not a well-studied treatment.

What are the outcomes for patients who experience a cytokine storm?

There isn’t much data available on how many patients recover from cytokine storms, especially ones caused by the novel coronavirus, though Dr. Fichtenbaum says the fatality rate is higher for patients who experience this heightened inflammatory response.

What’s more, Dr. Gotur says that since many people are already experiencing a storm by the time they finally get themselves to the hospital, it’s often difficult to avoid serious interventions like life support and ECMO.

Still, her team is working hard to prevent patients from ever reaching the storm phase. At Houston Methodist, clinicians have mobilized to determine how to treat every patient in every stage of the disease, using all their resources—from experimental medications to oxygen treatments—in hopes avoiding the kind of hyper-inflammatory response that requires more serious interventions or, ultimately, can lead to fatalities.

"We quickly realized we needed to start utilizing our resources earlier to prevent patients from being intubated or going on life support," Dr. Gotur says. "Our mortality is low because we have a set algorithm and approach for every stage of this disease process. We have instances where we feel we have prevented the patient from needing a ventilator or ECMO support."

Moving forward, Dr. Fichtenbaum says it will be important for experts to perform controlled studies to answer a few key questions if we want to have better outcomes for patients regarding cytokine storms:

    Who is at most risk, and is there a way we can predict a storm before it happens?
    Can preemptive strategies and therapies be successful?
    Once a storm happens, can we treat it effectively with mediator blockers or other medications that interfere with the cytokine storm pathway?

We don’t currently have that research, but clinical trials are ongoing in the midst of the pandemic, with clinicians tracking and reporting on all of the medications, therapies, and strategies they’re using to treat COVID-19 patients. With more answers, we could hopefully see more patient recoveries and success stories, too.

The information in this story is accurate as of press time. However, as the situation surrounding COVID-19 continues to evolve, it's possible that some data have changed since publication. While Health is trying to keep our stories as up-to-date as possible, we also encourage readers to stay informed on news and recommendations for their own communities by using the CDC, WHO, and their local public health department as resources.

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement

Two experimental Alzheimer's drugs show improvement in memory and anti-ageing

Researchers have found that two experimental Alzheimer's drugs, known as CMS121 and J147, improve memory and slow the degeneration of brain cells. The research suggests that the drugs may be useful for treating a broader array of conditions and points out a new pathway that links normal ageing to Alzheimer's disease. "This study further validated these two compounds not only as Alzheimer's drug candidates but also as potentially more widely useful for their anti-aging effects," said the study's co-author.

The researchers have shown how these compounds can slow ageing in healthy older mice, blocking the damage to brain cells that normally occurs during ageing and restoring the levels of specific molecules to those seen in younger brains.

Old age is the biggest risk factor for Alzheimer's disease and above the age of 65, a person's risk of developing the disease doubles about every five years.

"The contribution of old age-associated detrimental processes to the disease has been largely neglected in Alzheimer's disease drug discovery," said a staff scientist and first author of the new paper.

In the new study, the researchers turned to a strain of mice that age unusually fast.

A subset of these mice was given CMS121 or J147 beginning at nine months old -- the equivalent to late middle age in humans.

After four months, the team tested the memory and behaviour of the animals and analysed the genetic and molecular markers in their brains.

Not only did the animals given either of the drug candidates performed better on memory tests than mice that had not received any treatment, but their brains also showed differences at the cellular and molecular levels.

In particular, the expression of genes associated with the cell's energy-generating structures called mitochondria was preserved by CMS121 and J147 with ageing.

"The bottom line was that these two compounds prevent molecular changes that are associated with ageing," said the researcher.

More detailed experiments showed that both drugs affected mitochondria by increasing levels of the chemical acetyl-coenzyme A (acetyl-coA).

this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     
https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement